Back
Celldex Therapeutics Stock Price Chart
Sponsored
CLDX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
57
CLDX
Celldex Therapeutics
Last Price:
41.23
Seasonality Move:
-1.09%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- The current trend is moderately bullish and CLDX is experiencing slight buying pressure.
Celldex Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.99 | Sell |
20-day SMA: | 41.32 | Sell |
50-day SMA: | 38.51 | Buy |
200-day SMA: | 38.76 | Buy |
8-day EMA: | 41.74 | Sell |
20-day EMA: | 40.88 | Buy |
50-day EMA: | 39.17 | Buy |
200-day EMA: | 37.58 | Buy |
Celldex Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.21 | Buy |
Relative Strength Index (14 RSI): | 53.83 | Buy |
Chaikin Money Flow: | 95335 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.1 - 43.14) | Buy |
Bollinger Bands (100): | (34.55 - 41.03) | Buy |
Celldex Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 41.24 while CLDX 8-day simple moving average is 41.99, which is a Sell signal.
- The stock price of CLDX is 41.24 while Celldex Therapeutics 20-day SMA is 41.32, which makes it a Sell.
- Celldex Therapeutics 50-day simple moving average is 38.51 while CLDX share price is 41.24, making it a Buy technically.
- CLDX stock price is 41.24 and Celldex Therapeutics 200-day simple moving average is 38.76, creating a Buy signal.
CLDX Technical Analysis vs Fundamental Analysis
Buy
57
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Buy
The current Celldex Therapeutics [CLDX] share price is $41.24. The Score for CLDX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
2.73B
Price in USD:
41.24
Share Volume:
908.86K
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
22.11
Buy
57
Celldex Therapeutics (CLDX)
is a Buy
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 41.24 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is not overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 41.24 while CLDX 8-day exponential moving average is 41.74, which is a Sell signal.
- The stock price of CLDX is 41.24 while Celldex Therapeutics 20-day EMA is 40.88, which makes it a Buy.
- Celldex Therapeutics 50-day exponential moving average is 39.17 while CLDX share price is 41.24, making it a Buy technically.
- CLDX stock price is 41.24 and Celldex Therapeutics 200-day simple moving average is 37.58, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is 1.21, suggesting Celldex Therapeutics is a Buy
- Celldex Therapeutics Relative Strength Index (RSI) is 53.83, which suggest Celldex Therapeutics is overbought
- The Bollinger Bands (25) for Celldex Therapeutics is (37.1 - 43.14), which suggest Celldex Therapeutics is a Buy
- The Bollinger Bands (100) for Celldex Therapeutics is (34.55 - 41.03), which suggest Celldex Therapeutics is a Buy
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.